{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:29:41Z","timestamp":1783661381686,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jbc.2024.107507","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T18:02:09Z","timestamp":1719511329000},"page":"107507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9243-0240","authenticated-orcid":false,"given":"Laura","family":"Leimu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1637-0669","authenticated-orcid":false,"given":"Anna","family":"G\u0105ciarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Haavisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4916-5876","authenticated-orcid":false,"given":"Stuart","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9962-212X","authenticated-orcid":false,"given":"Ullamari","family":"Pesonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0960-3249","authenticated-orcid":false,"given":"Tuomas","family":"Huovinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-1407","authenticated-orcid":false,"given":"Urpo","family":"Lamminm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107507_bib1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI115118","article-title":"Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin","volume":"87","author":"Maury","year":"1991","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2024.107507_bib2","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1093\/emboj\/20.22.6277","article-title":"Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization","volume":"20","author":"Chen","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107507_bib3","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1038\/sj.emboj.7600872","article-title":"Metalloendoprotease cleavage triggers gelsolin amyloidogenesis","volume":"24","author":"Page","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107507_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-020-1300-5","article-title":"Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study","volume":"15","author":"Schmidt","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jbc.2024.107507_bib5","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/mt.2014.132","article-title":"Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model","volume":"22","author":"Van Overbeke","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2024.107507_bib6","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1093\/hmg\/ddv010","article-title":"An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model","volume":"24","author":"Van Overbeke","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2024.107507_bib7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/hmg\/ddx056","article-title":"AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model","volume":"26","author":"Verhelle","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2024.107507_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2024.107507_bib9","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s11010-021-04085-6","article-title":"Aggregation of gelsolin wild-type and G167K\/R, N184K, and D187N\/Y mutant peptides and inhibition","volume":"476","author":"Ahmad","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jbc.2024.107507_bib10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/cn500002v","article-title":"Selective interception of gelsolin amyloidogenic stretch results in conformationally distinct aggregates with reduced toxicity","volume":"5","author":"Arya","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jbc.2024.107507_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213973","article-title":"Rational design of a peptidomimetic inhibitor of gelsolin amyloid aggregation","volume":"23","author":"Bollati","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107507_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127011","article-title":"Gelsolin amyloidogenesis is effectively modulated by curcumin and emetine conjugated PLGA nanoparticles","volume":"10","author":"Srivastava","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107507_bib13","doi-asserted-by":"crossref","first-page":"13720","DOI":"10.1021\/jacs.7b05012","article-title":"Molecular mechanism for the (\u2212)-epigallocatechin gallate-induced toxic to nontoxic remodeling of A\u03b2 oligomers","volume":"139","author":"Ahmed","year":"2017","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107507_bib14","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in\u00a0vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107507_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1021\/acschemneuro.9b00673","article-title":"Ginnalin A inhibits aggregation, reverses fibrillogenesis, and alleviates cytotoxicity of amyloid \u03b2(1\u201342)","volume":"11","author":"Fan","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jbc.2024.107507_bib16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.neuint.2012.08.012","article-title":"The binding of resveratrol to monomer and fibril amyloid beta","volume":"61","author":"Ge","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jbc.2024.107507_bib17","article-title":"Small-molecule sequestration of amyloid-\u03b2 as a drug discovery strategy for Alzheimer\u2019s disease","volume":"6","author":"Heller Gabriella","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2024.107507_bib18","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1021\/acs.jcim.0c00381","article-title":"Small molecule modulation of intrinsically disordered proteins using molecular dynamics simulations","volume":"60","author":"Herrera-Nieto","year":"2020","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jbc.2024.107507_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41594-020-0505-6","article-title":"Kinetic fingerprints differentiate the mechanisms of action of anti-A\u03b2 antibodies","volume":"27","author":"Linse","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107507_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s43587-022-00284-y","article-title":"Monoclonal antibody therapies in Parkinson\u2019s disease","volume":"2","author":"Aman","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.jbc.2024.107507_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.654739","article-title":"Immunotherapies for neurodegenerative diseases","volume":"12","author":"Mortada","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jbc.2024.107507_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-323-85555-6.00019-9","article-title":"Lessons from antiamyloid-\u03b2 immunotherapies in Alzheimer's disease","volume":"193","author":"Plascencia-Villa","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jbc.2024.107507_bib23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","article-title":"Anti-amyloid immunotherapies for Alzheimer's disease: a 2023 clinical update","volume":"20","author":"Yadollahikhales","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jbc.2024.107507_bib24","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.1182\/blood-2022-157659","article-title":"Efficacy and safety of anti-amyloid antibodies in patients with AL amyloidosis: a systematic review of literature","volume":"140","author":"Ashraf","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2024.107507_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.jbc.2024.107507_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp-2021-327909","article-title":"Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis","volume":"93","author":"Carroll","year":"2022","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jbc.2024.107507_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/B978-0-444-52902-2.00039-4","article-title":"Hereditary gelsolin amyloidosis","volume":"115","author":"Kiuru-Enari","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jbc.2024.107507_bib28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/protein\/gzr023","article-title":"Synthetic single-framework antibody library integrated with rapid affinity maturation by VL shuffling","volume":"24","author":"Brockmann","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.jbc.2024.107507_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/protein\/gzt037","article-title":"Two ScFv antibody libraries derived from identical VL-VH framework with different binding site designs display distinct binding profiles","volume":"26","author":"Huovinen","year":"2013","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.jbc.2024.107507_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106882","article-title":"Kinetic titration series with biolayer interferometry","volume":"9","author":"Frenzel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107507_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290179","article-title":"Development of an in\u00a0vitro aggregation assay for long synthetic polypeptide, amyloidogenic gelsolin fragment AGelD187N 173-242","volume":"18","author":"Leimu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107507_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jbc.2024.107507_bib33","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107507_bib34","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41467-019-09477-3","article-title":"Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms","volume":"10","author":"De","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107507_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tips.2013.12.005","article-title":"Chemical kinetics for drug discovery to combat protein aggregation diseases","volume":"35","author":"Arosio","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2024.107507_bib36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2024.107507_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nprot.2016.010","article-title":"Molecular mechanisms of protein aggregation from global fitting of kinetic models","volume":"11","author":"Meisl","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbc.2024.107507_bib38","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid \u03b2-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107507_bib39","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107507_bib40","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nprot.2010.72","article-title":"Preparation and characterization of toxic A\u03b2 aggregates for structural and functional studies in Alzheimer's disease research","volume":"5","author":"Jan","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbc.2024.107507_bib41","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.bbapap.2014.08.016","article-title":"Antibodies and protein misfolding: from structural research tools to therapeutic strategies","volume":"1844","author":"De Genst","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2024.107507_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100508","article-title":"Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity","volume":"296","author":"Desai","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107507_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105252","article-title":"Anti-tau antibodies targeting a conformation-dependent epitope selectively bind seeds","volume":"299","author":"Hitt","year":"2023","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107507_bib44","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1074\/jbc.RA118.004731","article-title":"Nature-inspired design and evolution of anti-amyloid antibodies","volume":"294","author":"Julian","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107507_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105010","article-title":"Passive immunotherapies targeting A\u03b2 and tau in Alzheimer's disease","volume":"144","author":"Plotkin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2024.107507_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-022-00903-7","article-title":"Slowing Parkinson\u2019s disease progression with vaccination and other immunotherapies","volume":"36","author":"Vijayakumar","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jbc.2024.107507_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46112","article-title":"An engineered monomer binding-protein for \u03b1-synuclein efficiently inhibits the proliferation of amyloid fibrils","volume":"8","author":"Agerschou","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2024.107507_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40478-018-0543-z","article-title":"A\u00a0common antigenic motif recognized by naturally occurring human VH5-51\/VL4-1 anti-tau antibodies with distinct functionalities","volume":"6","author":"Apetri","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2024.107507_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700488","article-title":"Selective targeting of primary and secondary nucleation pathways in A\u03b242 aggregation using a rational antibody scanning method","volume":"3","author":"Aprile","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2024.107507_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41594-020-0384-x","article-title":"A\u00a0short motif in the N-terminal region of [alpha]-synuclein is critical for both aggregation and function","volume":"27","author":"Doherty","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107507_bib51","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A\u00a0hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107507_bib52","first-page":"558","article-title":"Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides","volume":"70","author":"Maury","year":"1994","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jbc.2024.107507_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcis.2020.03.075","article-title":"Revisiting thioflavin T (ThT) fluorescence as a marker of protein fibrillation \u2013 the prominent role of electrostatic interactions","volume":"573","author":"Arad","year":"2020","journal-title":"J.\u00a0Colloid Interf. Sci."},{"key":"10.1016\/j.jbc.2024.107507_bib54","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1111\/j.1742-4658.2009.07307.x","article-title":"The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds","volume":"276","author":"Hudson","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2024.107507_bib55","article-title":"Photophysical properties of fluorescent probe thioflavin T in crowded milieu","volume":"2017","author":"Rodina","year":"2017","journal-title":"J.\u00a0Spectrosc."},{"key":"10.1016\/j.jbc.2024.107507_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105122","article-title":"Flanking regions, amyloid cores, and polymorphism: the potential interplay underlying structural diversity","volume":"299","author":"Bhopatkar","year":"2023","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107507_bib57","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nbt.1691","article-title":"Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization","volume":"28","author":"Igawa","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2024.107507_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ddtec.2016.09.004","article-title":"Translational pharmacokinetics and pharmacodynamics of monoclonal antibodies","volume":"21-22","author":"Kamath","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jbc.2024.107507_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2024.107507_bib60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41573-022-00501-8","article-title":"Avidity in antibody effector functions and biotherapeutic drug design","volume":"21","author":"Oostindie","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2024.107507_bib61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12392","article-title":"Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation","volume":"270","author":"Igawa","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jbc.2024.107507_bib62","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2147\/JEP.S259298","article-title":"Current and future anti-VEGF agents for neovascular age-related macular degeneration","volume":"13","author":"Kaiser","year":"2021","journal-title":"J.\u00a0Exp. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107507_bib63","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the international society of amyloidosis (ISA) nomenclature committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2024.107507_bib64","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/1756-0500-7-661","article-title":"The selection performance of an antibody library displayed on filamentous phage coat proteins p9, p3 and truncated p3","volume":"7","author":"Huovinen","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jbc.2024.107507_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00223-020-00746-8","article-title":"Recombinant antibodies with unique specificities allow for sensitive and specific detection of uncarboxylated osteocalcin in human circulation","volume":"107","author":"Arponen","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jbc.2024.107507_bib66","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jim.2015.08.005","article-title":"Fast conversion of scFv to Fab antibodies using type IIs restriction enzymes","volume":"426","author":"Sanmark","year":"2015","journal-title":"J.\u00a0Immunol. Methods"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824020088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824020088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T21:25:49Z","timestamp":1728422749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824020088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0021925824020088"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107507","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107507"}}